Clinical Trials Directory

Trials / Terminated

TerminatedNCT03212144

The Anti-Inflammatory Effects of Exercise and Peanut Consumption

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
3 (actual)
Sponsor
New York State Psychiatric Institute · Academic / Other
Sex
All
Age
21 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study will enroll and randomly assign 30 sedentary, healthy overweight men and women to two groups. Participants will either start by consuming peanuts for 4 weeks, and then go on to exercise at high intensity intervals (HIIT) for 4 weeks, or the reverse order. The study will test and compare the effect of peanuts and exercise on inflammation and heart rate variability as indicators of heart health. Specifically, the study will measure inflammation in the blood because there is evidence that higher inflammation is found in heart disease patients. There is also evidence that inflammation is related to death as a result of heart disease in healthy individuals. Finally, there are ongoing trials targeting these markers to improve heart health. The study hypothesizes that peanuts and exercise will reduce inflammation. It is also expected to find less inflammation because exercise and peanut consumption activate a part of the nervous system that has been shown to cause a similar effect. Additionally, previous studies show that inflammation involves the mitochondria in the cell, the part of the cell that produces energy. For this reason, it is expected that exercise and peanuts will cause changes in the mitochondria. The study will test and compare mitochondrial activity in response to peanut consumption and exercise.

Conditions

Interventions

TypeNameDescription
OTHERHigh Intensity Interval TrainingSubjects will exercise according the the high intensity aerobic interval training regiment four times a week for four weeks
OTHERPeanut ConsumptionSubjects will consume peanuts twice a day to replace 20% of their daily caloric intake for four weeks.

Timeline

Start date
2017-08-20
Primary completion
2018-12-31
Completion
2019-12-31
First posted
2017-07-11
Last updated
2020-04-06
Results posted
2020-04-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03212144. Inclusion in this directory is not an endorsement.